Subject(s)
Humans , Male , Middle Aged , Peritonitis/complications , Peritonitis , Intestinal Obstruction/pathology , Intestinal Obstruction , Radiography, Abdominal/methods , Peritoneum/pathology , Peritoneum , Intestine, Small/pathology , Intestine, Small , Abdomen/pathology , Abdomen , Diagnosis, DifferentialABSTRACT
BACKGROUND: Lentils are increasingly consumed in many parts of the world.Two allergens, Len c 1 and 2, have been reported previously. Recently, peanut and green bean lipid transfer proteins (LTPs) have been identified as the first two members of an important group of allergens that might be associated with severe food allergies. OBJECTIVE: To investigate lentil LTP as a potential new allergen. METHODS: Efficacy of LTP extraction was monitored at different acidic pH values, using immunoblotting with cross-reactive anti-peach LTP antiserum. Natural LTP was purified from lentil extract and expressed as recombinant allergen in Escherichia coli. Sera from 10 lentil-allergic and/or -sensitized patients (Spain: 6, Italy: 1 and the Netherlands: 3) were used to further characterize lentil LTP. RESULTS: Natural lentil LTP, purified from the homogenized germinated seeds and optimally extracted at pH 3, was identified and designated as allergen Len c 3. By CAP, 9/10 sera showed specific IgE to Len c 3. Recombinant (r) Len c 3 was successfully purified. The natural (n) Len c 3 CAP was completely inhibited by rLen c 3/rPru p 3. IgE binding to lentil pH 3 extract blot was completely inhibited by rLen c 3. CONCLUSION: The availability of immunochemically active nLen/rLen c 3 as a novel legume allergen facilitates further development and implementation of a third (next to peanut and green bean) legume LTP in component-resolved diagnosis strategies and contributes to evaluate the clinical importance of legume LTPs. Preferential extraction of Len c 3 (pH 3) will affect the production of sensitive extract-based diagnostic tests.
Subject(s)
Allergens/immunology , Antigens, Plant/immunology , Carrier Proteins/immunology , Lens Plant/immunology , Plant Proteins/immunology , Adolescent , Adult , Child , Female , Food Hypersensitivity/immunology , Humans , Hydrogen-Ion Concentration , Immunoglobulin E/blood , Immunoglobulin E/immunology , Male , Middle Aged , Plant Extracts , Young AdultSubject(s)
Allergens/immunology , Dermatitis, Allergic Contact/immunology , Hypersensitivity, Immediate/immunology , Larva/immunology , Lepidoptera/immunology , Animals , Dermatitis, Allergic Contact/diagnosis , Female , Humans , Hypersensitivity, Immediate/diagnosis , Immunoblotting , Skin Tests , Urticaria/diagnosis , Young AdultABSTRACT
BACKGROUND: Delayed reactions with betalactam antibiotics are a very common reason for consultation and a matter of numerous publications. OBJECTIVE: To demonstrate that delayed reactions occurring during treatment with betalactam antibiotics are not reproduced in a high percentage of the patients, when making drug challenge. To analyse the characteristics of people showing this type of reaction. METHODS: We included in our study all the patients who came to our Allergy Department during one year (2004), with a clinical history of delayed reaction (> 72h) to betalactams. Skin prick tests (SPT), intradermal tests (IT) and patch tests were carried out, followed by simple blind placebo controlled drug challenge (SBPCDC) at hospital and home treatment with betalactams. RESULTS: We studied 23 patients (12 men and 11 women), average age 23.4 years old. SPT and patch test were negative in all patients. Only one patient showed positive IT tests, and allergic reaction was only reproduced in two patients; 76 % tolerated the drug involved in supposed allergy. CONCLUSIONS: Simple blind oral challenge with implicated drug followed by home treatment is required for a conclusive diagnosis of allergy in patients with delayed reactions to betalactams.
Subject(s)
Anti-Bacterial Agents/adverse effects , Hypersensitivity, Delayed/diagnosis , Hypersensitivity, Delayed/immunology , beta-Lactams/adverse effects , Adolescent , Adult , Aged , Anti-Bacterial Agents/immunology , Child , Child, Preschool , Female , Humans , Immunoglobulin E/blood , Infant , Male , Middle Aged , Patch Tests , Reproducibility of Results , Single-Blind Method , Skin Tests , Young Adult , beta-Lactams/immunologyABSTRACT
Background: Delayed reactions with betalactam antibiotics are a very common reason for consultationand a matter of numerous publications. Objective: To demonstrate that delayed reactions occurring during treatment with betalactam antibiotics are not reproduced in a high percentage of the patients, when making drug challenge.To analyse the characteristics of people showing this type of reaction. Methods: We included in our study all the patients who came to our Allergy Department during one year (2004), with a clinical history of delayed reaction (> 72h) to betalactams. Skin prick tests (SPT), intradermal tests (IT) and patch tests were carried out, followed by simple blind placebo controlled drug challenge (SBPCDC) at hospital and home treatment with betalactams. Results: We studied 23 patients (12 men and 11 women), average age 23.4 years old. SPT and patch test were negative in all patients. Only one patient showed positive IT tests, and allergic reaction was only reproduced in two patients; 76 % tolerated the drug involved in supposed allergy. Conclusions: Simple blind oral challenge with implicated drug followed by home treatment is required for a conclusive diagnosis of allergy in patients with delayed reactions to betalactams
No disponible
